PTJ
CGEM icon

Paul Tudor Jones’s Cullinan Oncology CGEM Stock Holding History

Paul Tudor Jones’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Sell
22,518
-6,470
-22% -$96.1K ﹤0.01% 2956
2026
Q1 		$412K Buy
28,988
+18,860
+186% +$242K ﹤0.01% 2948
2025
Q4 		$105K Sell
10,128
-18,860
-65% -$170K ﹤0.01% 3377
2025
Q3 		$172K Buy
28,988
+6,850
+31% +$50.2K ﹤0.01% 3219
2025
Q2 		$167K Buy
+22,138
New +$178K ﹤0.01% 3121

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Paul Tudor Jones's CGEM Position: Q2 2026 in Review

Paul Tudor Jones reduced its Cullinan Oncology (CGEM) stake by 22% in Q2 2026, selling an estimated $96.1K and leaving 22,518 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2956.

Paul Tudor Jones first reported a position in CGEM in Q2 2025 and has held it in 5 quarters since. The position peaked at $412K in Q1 2026. 182 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Paul Tudor Jones held 22,518 shares of Cullinan Oncology worth $410K as of Q2 2026.
  • Paul Tudor Jones sold 6,470 Cullinan Oncology shares in Q2 2026, an estimated $96.1K.
  • Cullinan Oncology made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2956 holding.
  • Paul Tudor Jones first reported a position in Cullinan Oncology in Q2 2025 and has held it in 5 quarters since.
  • Paul Tudor Jones's Cullinan Oncology position peaked at $412K in Q1 2026.
  • 182 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.